These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1973444)

  • 1. Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.
    Melder RJ; Walker ER; Herberman RB; Whiteside TL
    J Leukoc Biol; 1990 Aug; 48(2):163-73. PubMed ID: 1973444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term cultures of human peripheral blood lymphocytes with recombinant human interleukin-2 generate a population of virtually pure CD3+ CD16- CD56- large granular lymphocyte LAK cells.
    Roussel E; Gerrard JM; Greenberg AH
    Clin Exp Immunol; 1990 Nov; 82(2):416-21. PubMed ID: 1700746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural characteristics of lymphokine-activated killer cells of the rat in comparison with natural killer cells.
    Kaneda K; Nagamuta M; Kataoka M; Yamamoto H; Kishiye T; Wake K
    Arch Histol Cytol; 1991 May; 54(2):119-32. PubMed ID: 1873071
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gelatin sponge model of effector recruitment: tumoricidal activity of adherent and non-adherent lymphokine-activated killer cells after culture in interleukin-2.
    Akporiaye ET; Barbieri CA; Stewart CC; Bender JG
    J Leukoc Biol; 1991 Feb; 49(2):189-96. PubMed ID: 1991999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphokine-activated killer cells in rats. IV. Developmental relationships among large agranular lymphocytes, large granular lymphocytes, and lymphokine-activated killer cells.
    Maghazachi AA; Vujanovic NL; Herberman RB; Hiserodt JC
    J Immunol; 1988 Apr; 140(8):2846-52. PubMed ID: 3258622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lysis of autologous human macrophages by lymphokine-activated killer cells: interaction of effector cell and target cell conjugates analyzed by scanning electron microscopy.
    Streck RJ; Helinski EH; Ovak GM; Pauly JL
    J Leukoc Biol; 1990 Sep; 48(3):237-46. PubMed ID: 2391448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Changes in homing receptor expression on murine lymphokine-activated killer cells during IL-2 exposure.
    Steen PD; McGregor JR; Lehman CM; Samlowski WE
    J Immunol; 1989 Dec; 143(12):4324-30. PubMed ID: 2687380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adhesion molecules on MHC-nonrestricted lymphocytes: high density expression and role in oncolysis.
    Savary CA; Lotzová E
    Lymphokine Cytokine Res; 1992 Jun; 11(3):149-56. PubMed ID: 1391234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.
    Grimm EA; Mazumder A; Zhang HZ; Rosenberg SA
    J Exp Med; 1982 Jun; 155(6):1823-41. PubMed ID: 6176669
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro and in vivo comparison of the activity of human lymphokine-activated killer (LAK) cells and adherent LAK cells.
    Jemma C; Cignetti A; Geuna M; Caretto P; Vai S; Forni G
    J Immunother (1991); 1991 Jun; 10(3):189-99. PubMed ID: 1868043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Morphologic analysis of human lymphokine-activated killer (LAK) cells.
    Groscurth P; Diener S; Stahel R; Jost L; Kägi D; Hengartner H
    Int J Cancer; 1990 Apr; 45(4):694-704. PubMed ID: 2157676
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of T cells on the expression of lymphokine-activated killer cell activity and in vivo tissue distribution.
    Maghazachi AA; Goldfarb RH; Herberman RB
    J Immunol; 1988 Dec; 141(11):4039-46. PubMed ID: 2846699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytolysis of human dendritic cells by autologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing.
    Parajuli P; Nishioka Y; Nishimura N; Singh SM; Hanibuchi M; Nokihara H; Yanagawa H; Sone S
    J Leukoc Biol; 1999 Jun; 65(6):764-70. PubMed ID: 10380897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal transduction via phosphorylated adhesion molecule, LFA-1 beta (CD18), is increased by culture of natural killer cells with IL-2 in the generation of lymphokine-activated killer cells.
    Umehara H; Takashima A; Minami Y; Bloom ET
    Int Immunol; 1993 Jan; 5(1):19-27. PubMed ID: 8095153
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of lymphokine-activated killer cells and A549 lung carcinoma nodules maintained in three-dimensional culture.
    Gharib M; Tamboise E; Tamboise A; Lièvre N; Vérola O; Beaupain R
    Tumour Biol; 1997; 18(3):135-45. PubMed ID: 9143410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel CD56- lymphokine-activated killer cell precursor in cancer patients receiving recombinant interleukin 2.
    McKenzie RS; Simms PE; Helfrich BA; Fisher RI; Ellis TM
    Cancer Res; 1992 Nov; 52(22):6318-22. PubMed ID: 1384959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation and characterization of purified adherent lymphokine-activated killer cells in mice.
    Gunji Y; Vujanovic NL; Hiserodt JC; Herberman RB; Gorelik E
    J Immunol; 1989 Mar; 142(5):1748-54. PubMed ID: 2783950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-activated killer cells in rats: analysis of progenitor and effector cell phenotype and relationship to natural killer cells.
    Vujanovic NL; Herberman RB; Olszowy MW; Cramer DV; Salup RR; Reynolds CW; Hiserodt JC
    Cancer Res; 1988 Feb; 48(4):884-90. PubMed ID: 3257412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-2 modulates the expression of lymphocyte function-associated antigen-one (LFA-1) and p150,95 during the generation of lymphokine-activated killer (LAK) cells.
    Grant AJ; Merchant RE; Hall RE
    Immunology; 1989 Jan; 66(1):117-24. PubMed ID: 15493273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.